welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Brain Tumors in Individuals with Familial Adenomatous Polyposis: A Cancer Registry Experience and Pooled Case Report Analysis
source: Cancer
year: 2007
authors: Thomas M. Attard, Pierre Giglio, Sireesha Koppula, Carrie Snyder, Henry T. Lynch
summary/abstract:BACKGROUND : Most individuals with Familial Adenomatous Polyposis (FAP) harbor mutations in the APC gene on chromosome 5q21. They are at an increased risk of brain tumors, including cerebellar medulloblastoma, when compared with the general population (Brain Tumor Polyposis-BTP Type 2). Genotype-phenotype correlations between APC gene mutations and central nervous system (CNS) tumors have, thus far not been successful. Herein the authors have pooled their registry experience in BTP type 2 with the published reports.
METHODS : The authors analyzed their established hereditary CRC Registry for brain tumors in FAP pedigrees (56 families, 213 individuals), pooled their patients with BTP and known APC mutations with those reported thus far elsewhere, and compared the resulting mutation distribution of FAP-BTP with the mutation distribution for APC mutations in the US.
RESULTS : Twenty-eight patients from 24 families were accrued, the most common brain tumor in BTP was medulloblastoma (60%) predominantly in females (12:5) under the age of 20 (mean age 14.7 SD 9.2). Other histologic subtypes included astrocytoma and ependymoma. Analysis of the pooled APC mutation data by Chi-square test of association shows an odds ratio of 3.7 (P < .005) for all brain tumor subtypes and 13.1 (P < .001) for medulloblastoma in patients harboring segment 2 APC mutation (codons 679-1224) compared to nonsegment 2 mutation.
CONCLUSIONS : In patients with FAP and identifiable APC gene mutation, CNS tumors, especially medulloblastoma which developed in most cases during childhood, are more common in females with FAP and APC gene mutation in codons 686-1217. Further studies are necessary to determine if this observation and the natural history of medulloblastoma in children justifies novel, aggressive, targeted screening of at-risk individuals.
organization: University of Nebraska Medical Center, Creighton University School of Medicineread more full text source
expertly curated content related to this topic
-
High-Dose Tamoxifen and Sulindac as First-Line Treatment for Desmoid TumorsBACKGROUND : Desmoid tumors are mesenchy...
-
A 17-Year-Old Boy with Familial Adenomatous Polyposis and Unexpected Endoscopy FindingsA 17-year-old boy with familial adenomat...
-
Rectal Cancers in Patients with Familial Adenomatous PolyposisPatients with familial adenomatous polyp...
-
Assessment of Endostatin Gene Therapy for Familial Adenomatous Polyposis-related Desmoid TumorsConstitutive activation of the Wnt signa...
-
A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner SyndromeThe purpose of this study is to assess t...
-
Genotype and Phenotype of Patients with Both Familial Adenomatous Polyposis and Thyroid CarcinomaThe incidence of thyroid carcinoma in fa...
-
Familial Adenomatous PolyposisFamilial adenomatous polyposis (FAP) is ...